HAL vs MIRM · P/E 9.3, $19.05B cap vs rev $336.9M
Halliburton Company (HAL) versus Mirum Pharmaceuticals Inc (MIRM) — a side-by-side from cached financials, not a winner call.
Halliburton Company (HAL) is a oil & gas equipment & services company listed on US.
Mirum Pharmaceuticals Inc (MIRM) is a biotechnology company listed on NASDAQ.
HAL does not have a complete income-statement cache yet.
Latest reported MIRM revenue for 2024-12-31 was $336.9M. Net income was -$87.9M. Revenue was up 80.8% from 2023-12-31 to 2024-12-31. MIRM currently screens at market cap $6.22B.
HAL currently screens at market cap $19.05B and trailing P/E 9.3. MIRM currently screens at market cap $6.22B.
Not investment advice. Open the HAL and MIRM stock pages for the full models.
Not investment advice.